Cargando…

Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is closely associated with liver fibrosis. Hepatic stellate cells (HSC) and cancer-associated myofibroblasts are key players in liver fibrogenesis and hepatocarcinogenesis. Overexpression of fibroblast growth factor (FGF) receptors contributes to HCC development and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seitz, Tatjana, Freese, Kim, Dietrich, Peter, Thasler, Wolfgang Erwin, Bosserhoff, Anja, Hellerbrand, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066162/ https://www.ncbi.nlm.nih.gov/pubmed/32161315 http://dx.doi.org/10.1038/s41598-020-61510-4

Ejemplares similares

Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
por: Seitz, Tatjana, et al.
Publicado: (2022)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
por: Freese, Kim, et al.
Publicado: (2019)

Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option
por: Dietrich, Peter, et al.
Publicado: (2017)

Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro
por: Mahli, Abdo, et al.
Publicado: (2019)

Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells
por: Seitz, Tatjana, et al.
Publicado: (2021)

Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro
por: Kersten, Vanessa, et al.
Publicado: (2023)

Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury
por: Sommer, Judith, et al.
Publicado: (2020)

The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression
por: Dietrich, Peter, et al.
Publicado: (2019)

Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice
por: Sommer, Judith, et al.
Publicado: (2016)

Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma
por: Fritz, Valerie, et al.
Publicado: (2021)

Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()
por: Dietrich, Peter, et al.
Publicado: (2019)

Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
por: Linck-Paulus, Lisa, et al.
Publicado: (2020)

Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11
por: Gaza, Anne, et al.
Publicado: (2021)

The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
por: Weiskirchen, Ralf, et al.
Publicado: (2015)

Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth Factors
por: Schumacher, Justin D., et al.
Publicado: (2016)

Expression and Function of Methylthioadenosine Phosphorylase in Chronic Liver Disease
por: Czech, Barbara, et al.
Publicado: (2013)

Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin
por: Mogler, Carolin, et al.
Publicado: (2017)

Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease
por: Mahli, Abdo, et al.
Publicado: (2019)

UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
por: Massoumi, Ramin, et al.
Publicado: (2009)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro
por: Mahli, Abdo, et al.
Publicado: (2015)

Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
por: Yu, Guofeng, et al.
Publicado: (2013)

mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
por: Scheller, T, et al.
Publicado: (2015)

Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis
por: Tsuchiya, Yuichi, et al.
Publicado: (2023)

BMP-9 Modulates the Hepatic Responses to LPS
por: Gaitantzi, Haristi, et al.
Publicado: (2020)

Lipid Accumulation in Host Cells Promotes SARS-CoV-2 Replication
por: Seitz, Tatjana, et al.
Publicado: (2023)

Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
por: Quiroz Reyes, Adriana G., et al.
Publicado: (2023)

CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma
por: Li, Zhi-Qiang, et al.
Publicado: (2018)

Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation
por: Imai, Yusuke, et al.
Publicado: (2019)

HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma
por: Chen, Qi-tao, et al.
Publicado: (2022)

Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun’s Nuclear Translocation and Activity
por: Kappelmann-Fenzl, Melanie, et al.
Publicado: (2019)

Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells
por: Opoku, Yeboah Kwaku, et al.
Publicado: (2020)

Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts
por: Zhou, Yuan, et al.
Publicado: (2018)

Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells via Facilitating the Expression and Secretion of ENPP2
por: Deng, Wanyu, et al.
Publicado: (2021)

The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis
por: Liu, Boqiang, et al.
Publicado: (2022)

Epigenetic Changes during Hepatic Stellate Cell Activation
por: Götze, Silke, et al.
Publicado: (2015)

Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity
por: Sommer, Judith, et al.
Publicado: (2023)

Epigenetic regulation during hepatic stellate cell activation
por: Götze, Silke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6ji7r7nktsv9j2lu9vce63e7mi